Evidence map›Paper›PMID 35416690›Full record

ArticleJournal of bacteriology2022

The Atypical Antipsychotic Quetiapine Promotes Multiple Antibiotic Resistance in Escherichia coli.

Yasuhiro Kyono, Lori Ellezian, YueYue Hu, Kanella Eliadis, Junlone Moy, Elizabeth B Hirsch, Michael J Federle, Stephanie A Flowers

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yasuhiro KyonoDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
Lori EllezianDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
YueYue HuDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
Kanella EliadisDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
Junlone MoyDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
Elizabeth B HirschDepartment of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-0462-0421
Michael J FederleDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.ORCID 0000-0002-4554-543X
Stephanie A FlowersDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.ORCID 0000-0001-5149-9444
University of Illinois Urbana-Champaign · USUniversity of Illinois Chicago · USUniversity of Minnesota · US

Funding

Mechanistic Dissection of Pheromone-Dependent Regulation of Group A StreptococcalR01AI091779 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FEDERLE, MICHAEL J · 2011 to 2021
$3.9M
NIAID NIH HHS R01 AI091779
6 · The paper itself

Abstract

Atypical antipsychotic (AAP) medication is a critical tool for treating symptoms of psychiatric disorders. While AAPs primarily target dopamine (D2) and serotonin (5HT2A and 5HT1A) receptors, they also exhibit intrinsic antimicrobial activity as an off-target effect. Because AAPs are often prescribed to patients for many years, a potential risk associated with long-term AAP use is the unintended emergence of bacteria with antimicrobial resistance (AMR). Here, we show that exposure to the AAP quetiapine at estimated gut concentrations promotes AMR in Escherichia coli after 6 weeks. Quetiapine-exposed isolates exhibited an increase in MICs for ampicillin, tetracycline, ceftriaxone, and levofloxacin. By whole-genome sequencing analysis, we identified mutations in genes that confer AMR, including the repressor for the multiple antibiotic resistance

Indexed as

Antipsychotic AgentsEscherichia coli InfectionsEscherichia coli ProteinsAnti-Bacterial AgentsDrug Resistance, MicrobialEscherichia coliHumansMicrobial Sensitivity TestsQuetiapine FumarateRepressor ProteinsAnti-Bacterial AgentsAntipsychotic AgentsEscherichia coli ProteinsQuetiapine FumarateRepressor Proteinsantimicrobial resistanceatypical antipsychotics

Identifiers

PMID35416690
PMCPMC9112998
OpenAlexW4223561225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.